vs
Apple Hospitality REIT, Inc.（APLE）与Esperion Therapeutics, Inc.（ESPR）财务数据对比。点击上方公司名可切换其他公司
Apple Hospitality REIT, Inc.的季度营收约是Esperion Therapeutics, Inc.的1.9倍（$326.4M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -2.0%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -0.5%）
莱曼 hospitality properties是一家深耕酒店、度假村、娱乐及媒体领域的企业，得名于旗下核心资产——位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾作为爱德华·盖洛德旗下俄克拉荷马出版公司子公司的时期，1983年收购WSM公司后，拿下大奥普里等知名IP，奠定了如今的业务发展基础。
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
APLE vs ESPR — 直观对比
营收规模更大
APLE
是对方的1.9倍
$168.4M
营收增速更快
ESPR
高出145.7%
-2.0%
两年增速更快
ESPR
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $326.4M | $168.4M |
| 净利润 | $29.6M | — |
| 毛利率 | 37.2% | — |
| 营业利润率 | 15.2% | 50.6% |
| 净利率 | 9.1% | — |
| 营收同比 | -2.0% | 143.7% |
| 净利润同比 | -0.7% | — |
| 每股收益（稀释后） | $0.13 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLEESPR
| Q4 25 | $326.4M | $168.4M | ||
| Q3 25 | $373.9M | $87.3M | ||
| Q2 25 | $384.4M | $82.4M | ||
| Q1 25 | $327.7M | $65.0M | ||
| Q4 24 | $333.0M | $69.1M | ||
| Q3 24 | $378.8M | $51.6M | ||
| Q2 24 | $390.1M | $73.8M | ||
| Q1 24 | $329.5M | $137.7M |
净利润APLEESPR
| Q4 25 | $29.6M | — | ||
| Q3 25 | $50.9M | $-31.3M | ||
| Q2 25 | $63.6M | $-12.7M | ||
| Q1 25 | $31.2M | $-40.5M | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $56.3M | $-29.5M | ||
| Q2 24 | $73.9M | $-61.9M | ||
| Q1 24 | $54.0M | $61.0M |
毛利率APLEESPR
| Q4 25 | 37.2% | — | ||
| Q3 25 | 40.6% | — | ||
| Q2 25 | 42.6% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 41.9% | — | ||
| Q2 24 | 44.6% | — | ||
| Q1 24 | 40.1% | — |
营业利润率APLEESPR
| Q4 25 | 15.2% | 50.6% | ||
| Q3 25 | 19.4% | -11.4% | ||
| Q2 25 | 22.1% | 8.6% | ||
| Q1 25 | 15.5% | -34.0% | ||
| Q4 24 | 15.0% | -6.4% | ||
| Q3 24 | 20.5% | -31.0% | ||
| Q2 24 | 24.0% | 3.5% | ||
| Q1 24 | 21.7% | 52.5% |
净利率APLEESPR
| Q4 25 | 9.1% | — | ||
| Q3 25 | 13.6% | -35.9% | ||
| Q2 25 | 16.6% | -15.4% | ||
| Q1 25 | 9.5% | -62.2% | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 14.9% | -57.2% | ||
| Q2 24 | 19.0% | -83.9% | ||
| Q1 24 | 16.4% | 44.3% |
每股收益（稀释后）APLEESPR
| Q4 25 | $0.13 | $0.32 | ||
| Q3 25 | $0.21 | $-0.16 | ||
| Q2 25 | $0.27 | $-0.06 | ||
| Q1 25 | $0.13 | $-0.21 | ||
| Q4 24 | $0.13 | $-0.14 | ||
| Q3 24 | $0.23 | $-0.15 | ||
| Q2 24 | $0.31 | $-0.33 | ||
| Q1 24 | $0.22 | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $167.9M |
| 总债务越低越好 | $1.5B | — |
| 股东权益账面价值 | $3.1B | $-302.0M |
| 总资产 | $4.9B | $465.9M |
| 负债/权益比越低杠杆越低 | 0.49× | — |
8季度趋势，按日历期对齐
现金及短期投资APLEESPR
| Q4 25 | $8.5M | $167.9M | ||
| Q3 25 | $50.3M | $92.4M | ||
| Q2 25 | $7.9M | $86.1M | ||
| Q1 25 | $14.9M | $114.6M | ||
| Q4 24 | $10.3M | $144.8M | ||
| Q3 24 | $6.1M | $144.7M | ||
| Q2 24 | $7.2M | $189.3M | ||
| Q1 24 | $4.9M | $226.6M |
总债务APLEESPR
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
股东权益APLEESPR
| Q4 25 | $3.1B | $-302.0M | ||
| Q3 25 | $3.2B | $-451.4M | ||
| Q2 25 | $3.2B | $-433.5M | ||
| Q1 25 | $3.2B | $-426.2M | ||
| Q4 24 | $3.3B | $-388.7M | ||
| Q3 24 | $3.3B | $-370.2M | ||
| Q2 24 | $3.3B | $-344.2M | ||
| Q1 24 | $3.3B | $-294.3M |
总资产APLEESPR
| Q4 25 | $4.9B | $465.9M | ||
| Q3 25 | $4.9B | $364.0M | ||
| Q2 25 | $4.9B | $347.1M | ||
| Q1 25 | $4.9B | $324.0M | ||
| Q4 24 | $5.0B | $343.8M | ||
| Q3 24 | $5.0B | $314.1M | ||
| Q2 24 | $5.1B | $352.3M | ||
| Q1 24 | $5.0B | $373.1M |
负债/权益比APLEESPR
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.46× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.45× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $370.2M | $45.2M |
| 自由现金流经营现金流 - 资本支出 | $282.0M | — |
| 自由现金流率自由现金流/营收 | 86.4% | — |
| 资本支出强度资本支出/营收 | 27.0% | 0.0% |
| 现金转化率经营现金流/净利润 | 12.50× | — |
| 过去12个月自由现金流最近4个季度 | $516.8M | — |
8季度趋势，按日历期对齐
经营现金流APLEESPR
| Q4 25 | $370.2M | $45.2M | ||
| Q3 25 | $126.4M | $-4.3M | ||
| Q2 25 | $108.8M | $-31.4M | ||
| Q1 25 | $49.1M | $-22.6M | ||
| Q4 24 | $405.4M | $-35.0M | ||
| Q3 24 | $128.2M | $-35.3M | ||
| Q2 24 | $127.3M | $-7.2M | ||
| Q1 24 | $54.7M | $53.8M |
自由现金流APLEESPR
| Q4 25 | $282.0M | — | ||
| Q3 25 | $109.0M | — | ||
| Q2 25 | $96.2M | — | ||
| Q1 25 | $29.5M | — | ||
| Q4 24 | $327.1M | — | ||
| Q3 24 | $113.1M | $-35.5M | ||
| Q2 24 | $115.0M | $-7.3M | ||
| Q1 24 | $34.4M | $53.8M |
自由现金流率APLEESPR
| Q4 25 | 86.4% | — | ||
| Q3 25 | 29.2% | — | ||
| Q2 25 | 25.0% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 98.2% | — | ||
| Q3 24 | 29.9% | -68.7% | ||
| Q2 24 | 29.5% | -9.9% | ||
| Q1 24 | 10.4% | 39.0% |
资本支出强度APLEESPR
| Q4 25 | 27.0% | 0.0% | ||
| Q3 25 | 4.7% | 0.0% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 6.0% | 0.0% | ||
| Q4 24 | 23.5% | 0.0% | ||
| Q3 24 | 4.0% | 0.3% | ||
| Q2 24 | 3.2% | 0.1% | ||
| Q1 24 | 6.2% | 0.1% |
现金转化率APLEESPR
| Q4 25 | 12.50× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 1.71× | — | ||
| Q1 25 | 1.57× | — | ||
| Q4 24 | 13.59× | — | ||
| Q3 24 | 2.28× | — | ||
| Q2 24 | 1.72× | — | ||
| Q1 24 | 1.01× | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLE
| Occupancy | $293.0M | 90% |
| Hotel Other | $17.2M | 5% |
| Food And Beverage | $16.3M | 5% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
